Sign in

CIK 0001438533

  • Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
262383102
Phone
+1 888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,495,607
in 10 filings, $79.5M under 10b5-1 plans

Net −$79,495,607. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-12-18 ASELAGE STEVE Chief Executive Officer Grant or award +20,625 272,148
2018-12-07 ASELAGE STEVE Chief Executive Officer Sale −10 $24.04 $240 251,523
2018-11-29 ASELAGE STEVE Chief Executive Officer Gift −1,750 251,533
2018-11-15 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −2,300 $24.29 $56K 18,027
2018-11-15 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −100 $24.77 $2K 17,927
2018-11-15 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −100 $24.81 $2K 17,827
2018-11-15 ROTE WILLIAM E. Senior Vice President, R&D Sale −2,188 $24.25 $53K 18,304
2018-11-15 ROTE WILLIAM E. Senior Vice President, R&D Sale −312 $24.83 $8K 17,992
2018-11-15 Clague Laura Chief Financial Officer Sale −2,959 $24.20 $72K 12,824
2018-11-15 Clague Laura Chief Financial Officer Sale −791 $24.73 $20K 12,033
2018-11-15 ASELAGE STEVE Chief Executive Officer Sale −4,464 $24.21 $108K 254,369
2018-11-15 ASELAGE STEVE Chief Executive Officer Sale −1,086 $24.75 $27K 253,283
2018-11-14 McFarlane Neil F. Chief Operating Officer Sale −9,000 $23.63 $213K 29,476
2018-11-14 McFarlane Neil F. Chief Operating Officer Sale −1,000 $24.64 $25K 28,476
2018-11-14 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −2,200 $23.62 $52K 20,627
2018-11-14 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −300 $24.57 $7K 20,327
2018-11-14 ROTE WILLIAM E. Senior Vice President, R&D Sale −2,200 $23.62 $52K 20,792
2018-11-14 ROTE WILLIAM E. Senior Vice President, R&D Sale −300 $24.57 $7K 20,492
2018-11-14 Clague Laura Chief Financial Officer Sale −3,350 $23.63 $79K 16,183
2018-11-14 Clague Laura Chief Financial Officer Sale −400 $24.54 $10K 15,783

Page 49 of 51 · 1,020 trades